Ayala Pharmaceuticals Inc (ADXS)

[Traderbx]

So this may be a repeat, but very important to reiterate and is going to be the highlight for ESGO in November for ADXS:

GOG trail at 38% (the best) has potential to go up to 77% based on genetic biomarkers!!!

"In the GOG/NRG-0265 Phase 2 trial (NCT01266460), patients with persistent or recurrent metastatic carcinoma of the cervix treated with axal were 77 percent more likely to survive if they had low serum levels of a cluster of four proteins at the study’s start."

"Results from this trial showed a strong correlation between levels of four specific proteins and overall survival. The patients were stratified according to the levels of the four proteins in each patient. The first group of 25 patients had relatively low levels of all four proteins, and had an overall survival of 56%. The second group of 20 patients had relatively high levels of all four proteins, and had an overall survival of 15%. The 12-month overall survival of all patients in this trial was 38%."

Source:
https://immuno-oncologynews.com/2017/06/29/blood-protein-levels-may-identify-cervical-cancer-patients-likely-benefit-advaxis-drug-candidate/